Effect of a Classical Ayurvedic Regimen on Migraine (Ardhavabhedaka): A Short-term Case Report
Abstract
Migraine is a common and disabling neurological disorder affecting nearly 41 million adults. Episodic migraine (EM) is defined as having fewer than 15 headache days per month, whereas chronic migraine (CM) involves 15 or more headache days per month. It is a benign and recurrent syndrome characterized by headache, nausea, vomiting, and other neurological symptoms. In Ayurvedic texts, the condition is correlated with
Ardhavabhedaka
, one of the 11 types of
Shiro-Roga
described by Acharya Sushruta in
Uttar Tantra
. According to Ayurveda,
Ardhavabhedaka
is a
Tridoshaja
disorder, with predominance of
Vata
or
Vata-Kapha
dosha in its pathogenesis. In the present case, a 35-year-old male visited the Shalakya Tantra outdoor patient department at AIIA, New Delhi, with complaints of left-sided throbbing and pulsating headache associated with nausea, vomiting, and sensitivity to light and sound for the past 2 years. The condition had been unresponsive to conventional medicine. After Ayurvedic management, the patient experienced marked improvement in headache frequency and associated symptoms. Considering the relapsing–remitting nature of migraine, the outcome can be regarded as short-term remission. This case demonstrates that Ayurvedic management of
Ardhavabhedaka
can provide significant clinical benefits when planned systematically based on the disease pathology, causative factors, and clinical presentation. However, as this is a single-case observation, the results cannot be…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 41 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.